Autolus Therapeutics plc revenue breakdown overview

Autolus Therapeutics plc revenue for the last year amounted to 10.12 M USD, the most of which — 10.12 M USD — came from its highest performing source at the moment, Chimeric Antigen Receptors T Cell Therapies, the year earlier bringing 1.70 M USD. The greatest contribution to the revenue figure was made by Europe — last year it brought Autolus Therapeutics plc 10.12 M USD.